Literature DB >> 221156

Antiviral action of benzo[de]isoquinoline-1,3-diones: 5-nitro-2-(2-dimethylaminoethyl) and 5-nitro-2-[2-(1-pyrrolidine)-ethyl] derivatives.

A García-Gancedo, C Gil, C M Roldán, S Pérez, P Vilas.   

Abstract

Two benzo[de]isoquinoline-diones, namely 5-nitro-2-(2-dimethylaminoethyl)-benzo[de]isoquinoline-1,3-dione and 5-nitro-2-[2-(1-pyrrolidine)-ethyl]-benzo[de]isoquinoline-1,3-dione, caused inhibition of the viral replication, when assayed against herpes simplex and vaccinia viruses in chick embryo cell cultures. Influenza and Sindbis virus replication were unaffected by these chemicals. Virucidal effects were unobserved. The inhibitory activity is time-related. Ocular and dermal infections with vaccinia virus in rabbits were prevented or disease severity reduced whenever they were treated with either one of these two drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221156     DOI: 10.1159/000237827

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

1.  Acetonide Protection of Dopamine for the Synthesis of Highly Pure N-docosahexaenoyldopamine.

Authors:  Zhongqiang Liu; Bi-Huang Hu; Phillip B Messersmith
Journal:  Tetrahedron Lett       Date:  2010-05-01       Impact factor: 2.415

2.  Imide derivatives of 3-nitro-1.8-naphthalic acid: their inhibitory activity against DNA viruses.

Authors:  A Garcá Gancedo; C Gil-Fernández; P Vilas; S Perez; E Paez; F Rodriguez; M F Braña; C M Roldán
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Phase II study of amonafide in advanced pancreatic adenocarcinoma.

Authors:  K Linke; R Pazdur; J L Abbruzzese; J A Ajani; R Winn; J E Bradof; K Daugherty; B Levin
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

4.  The pharmacokinetics, tissue distribution, and biotransformation of a new class of antitumor agents: mitonafide and pinafide.

Authors:  P Rivera Cid; E Gonzalez Fernandez; F R Martin; M F Braña
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Oct-Dec       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.